MEDI DATA INTERNATIONAL INC
10QSB, 1996-10-10
MISCELLANEOUS RETAIL
Previous: NASTECH PHARMACEUTICAL CO INC, PRE 14A, 1996-10-10
Next: CONCORD EFS INC, SC 13G, 1996-10-10



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   Form 10-QSB



[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934 [Fee Required]

    For the quarter ended August 31, 1996  

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934 [No Fee Required]
     
    For the transition period from_______ to________

                         Commission File No. 2-88678-NY

                          MEDI-DATA INTERNATIONAL, INC.
- --------------------------------------------------------------------------------
                 (Name of small business issuer in its charter)

     New York                                         11-2653474
- --------------------------------------------------------------------------------
(State or other jurisdiction                       (I.R.S. Employer 
of incorporation)                                  Identification No.)

                20 Red Ground Road, Old Westbury, New York 11568
- --------------------------------------------------------------------------------
                    (Address of principal executive offices)

                    Issuer's telephone number: (516) 997-1155 
- --------------------------------------------------------------------------------
       Securities registered under Section 12(b) of the Exchange Act: None
         Securities registered under Section 12(g) of the Exchange Act:

                         Common Stock, $0.001 Par Value
                                (Title of Class)

     Check  whether  the issuer (1) filed all  reports  required  to be filed by
section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days.
Yes [ X ]    No [    ]

Number of shares  outstanding of the issuer's common equity, as of September 25,
1996 (exclusive of securities convertible into common equity): 9,212,551
<PAGE>                     
                                     Part I


Item 1.  Business Development

In  April  1988,  Medi-Data  International,  Inc.  (the  "Company")  ceased  all
operations.  When it was  operating,  the Company  had  devoted its  business to
developing  a program  to monitor  the  interaction  and misuse of  prescription
drugs,  over-the-counter medication and food supplements. For the quarters ended
August 31, 1996 and 1995 and for the years ended February 28, 1996 and 1995, the
Company had no operations or income from operations.

During the year ended  February 29,  1996,  the Company  invested in  marketable
securities which resulted in realized gains of $74,004. At February 29, 1996 all
of the marketable securities have been sold.

The company is  presently  seeking to acquire an  operating  company  either for
cash,  stock or a  combination  thereof.  There  are no  present  agreements  or
understandings  with  respect  to  such an  acquisition  nor  can  there  be any
assurance that the Company can make such an acquisition in the near future.

Item 2.  Properties

The Company does not lease or own any properties.

Item 3.  Legal Proceedings

To the Company's  knowledge,  there is no legal proceeding  pending to which the
Company is a party or to which any of their properties is subject.

Item 4.  Submission of Matters to a Vote of Security Holders

Not Applicable.
<PAGE>
                                     Part II

Item 5.  Market For Common Equity and Related Stockholder Matters.

Since the Company ceased operations in April 1988,  currently there is no market
for the Company's  Common Stock. The Company's Common Stock is listed on the OTC
Bulletin Board under the symbol "MDAD",  but no reported  public trades occurred
during the six months ended August 30, 1996.

The Company has paid no  dividends,  either in cash or in stock.  It is unlikely
that the Company will pay any dividends as it has ceased  operations as of April
1988.

Item 6.  Management's Discussion and Analysis of Financial Condition and Results
         of Operations.

Results of Operations
The Company  ceased all operations in April 1988. The Company only paid the $250
SEC filing fee for the 10Q and received $1 of interest income for the six months
ended August 31, 1996. There was no activity for the first quarter ended May 31,
1996.  During the second  quarter of 1995 the Company had invested in marketable
securities  which  resulted in an $124,381 gain on the sale of  securities.  The
three months ended August 31, 1995 had a net income of $117,492  with net income
for the six months ended August 31, 1995 of $ 113,641.

In 1995,  the Company  invested in  marketable  securities  which  resulted in a
realized gain for the year ended  February 29, 1996 of $74,004.  The Company had
no  investments  in securities for the current year. For the year ended February
28, 1996,  the Company had net income of $2,665 versus a net loss of $29,192 for
the fiscal year ended February 28, 1995.

In January  1994 the  Company  received a loan from Terry  Brooks,  a  principal
shareholder,  of $100,000 which was repaid in July 1995 from the proceeds of the
sale of marketable securities.  The loan bore interest at ten percent per annum.
In addition, Terry Brooks' IRA assumed a $25,000 loan from Marc Gold, the former
president of the  company.  This loan bore the same  interest  rate and was also
repaid in July 1995 from the proceeds of the sale of the marketable securities.

Liquidity and Capital Resources
The Company ceased all previous operations in April 1988, and for the six months
ended  August 31,  1996 and 1995 the company  had no  operations  or income from
operations.  During the quarter  ended  August 31, 1995 the Company  invested in
marketable securities and the proceeds were used to pay the shareholder loans in
full. All securities  were sold by the fiscal year end of February 1996, and the
Company does not has not made any additional investments. In the previous fiscal
year,  February 29, 1996 the Company  realized only interest  income and gain on
securities. The company had a net income for the fiscal year ended February 1996
of $2,665 and net loss for the fiscal year ended 1995 of $29,193.  At August 31,
1996 and 1995 the Company has a  shareholders'  deficiency of  $1,057,822  and $
946,596.  At the end of the fiscal year, February 1996 and 1995, the Company has
a shareholders' deficiency of $1,057,572 and $1,060,235 respectively.

Item 7. Financial Statements.

The Company's financial statements are set forth herein.
<PAGE>

Item 8.  Changes  in  and  Disagreements  with  Accountants  on  Accounting  and
         Financial Disclosure. No disagreements or changes occurred.

<TABLE>
<CAPTION>
                                       MEDI-DATA INTERNATIONAL, INC.
                                              BALANCE SHEETS

                                                                               Unaudited
                                                                               August 31,    February 29,
                                                                                  1996           1996
                                                                             -----------    -----------
                         ASSETS
<S>                                                                          <C>            <C>
CURRENT ASSETS
   Cash, including money market funds of $63                                 $       196    $       845
   Prepaid income taxes                                                              293           --
   Due from shareholder                                                            5,650          6,250
                                                                             -----------    -----------
         TOTAL ASSETS                                                        $     6,139    $     7,095
                                                                             ===========    ===========





                        LIABILITIES AND SHAREHOLDERS' DEFICIENCY IN ASSETS


CURRENT LIABILITIES
   Due to shareholders                                                       $      --      $      --
   Accrued expenses and other current liabilities                                 60,793         61,500
                                                                             -----------    -----------

         Total Current Liabilities                                                60,793         61,500
                                                                             -----------    -----------

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' DEFICIENCY IN ASSETS
   Common stock, $.001 par value 50,000,000 shares authorized,
    9,213,051 issued and outstanding                                               9,213          9,213
   Additional paid-in capital                                                    993,954        993,954
   Accumulated Deficit                                                        (1,057,821)    (1,057,572)
                                                                             -----------    -----------
         Total Shareholders' Deficiency in Assets                                (54,654)       (54,405)
                                                                             -----------    -----------

         TOTAL LIABILITIES AND
           SHAREHOLDERS' DEFICIENCY IN ASSETS                                $     6,139    $     7,095
                                                                             ===========    ===========
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                            MEDI-DATA INTERNATIONAL, INC.
                              STATEMENTS OF OPERATIONS

                                                         For the three months ended
                                                                  August 31,
                                                         --------------------------
                                                             1996           1995
                                                        -----------    ------------
<S>                                                     <C>            <C>
Costs & Expenses:
  Selling, general and administrative, including
      interest expense of 7,800 in 1995                 $       250    $     4,550
                                                        -----------    -----------

      Loss before other income and state income taxes          (250)        (4,550)
                                                        -----------    -----------

Other Income (Expenses):
  Interest and dividend income                                    1            342
  Realized gain on sale of securities                                      124,381
  Unrealized loss on securities                                --           (2,252)
                                                        -----------    -----------
  Total Other Income (Expense)                                    1        122,471

      Income (Loss) before state income taxes                  (249)       117,921

State income taxes                                             --              429
                                                        -----------    -----------

      Net Income (Loss)                                        (249)       117,492

      Accumulated Deficit - beginning                    (1,057,572)    (1,064,088)
                                                        -----------    -----------

      Accumulated Deficit - end                         $(1,057,821)   $  (946,596)
                                                        ===========    ===========

Income (Loss) per share                                 $      0.00    $      0.01
                                                        ===========    ===========

Primary and Fully Diluted Shares                          9,212,551      9,212,551
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                            MEDI-DATA INTERNATIONAL, INC.
                              STATEMENTS OF OPERATIONS



                                                         For the Six Months Ended
                                                                August 31,
                                                        ---------------------------
                                                             1996           1995
                                                        -----------   -------------
<S>                                                     <C>            <C>
Costs & Expenses:
  Selling, general and administrative, including
      interest expense of 7,800 in 1995                 $       250    $     8,806
                                                        -----------    -----------

      Loss before other income and state income taxes          (250)        (8,806)
                                                        -----------    -----------

Other Income (Expenses):
  Interest and dividend income                                    1            854
  Realized gain on sale of securities                                      124,381
  Unrealized loss on securities                                --           (2,252)
                                                        -----------    -----------
  Total Other Income (Expense)                                    1        122,983

      Income (Loss) before state income taxes                  (249)       114,177

State income taxes                                             --              536
                                                        -----------    -----------

      Net Income (Loss)                                        (249)       113,641

      Accumulated Deficit - beginning                    (1,057,572)    (1,060,237)
                                                        -----------    -----------

      Accumulated Deficit - end                         $(1,057,821)   $  (946,596)
                                                        ===========    ===========

Income (Loss) per share                                 $      0.00    $      0.01
                                                        ===========    ===========

Primary and Fully Diluted Shares                          9,212,551      9,212,551
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                 MEDI-DATA INTERNATIONAL, INC.
                               UNAUDITED STATEMENTS OF CASH FLOWS


                                                          FOR THE SIX MONTHS ENDED AUGUST 31,
                                                          -----------------------------------                               
                                                                    1996         1995
                                                                 ---------    ---------
<S>                                                              <C>          <C> 
Cash flows from operating activities

   Net Income (Loss)                                             $    (249)   $ 113,641
   Adjustments to reconcile net income to net cash provided by
     (used in) operating activities
   (Increase) Decrease In:
   Prepaid income taxes                                               (293)
   Other Assets                                                        600       (6,250)
   Marketable Securities                                                        (96,540)
   Increase (decrease) in:
   Accrued expenses and other current liabilities                     (707)      35,760
                                                                 ---------    ---------
   Net cash used in operating activities                              (649)      46,611

Cash flows from financing activities:
   Net proceeds from the issuance of common stock                                25,000
   Repayment of shareholders' loans                                   --       (125,000)
                                                                 ---------    ---------
         Net cash used in financing activities                           0     (100,000)
                                                                 ---------    ---------


   Net increase (decrease) in cash and cash equivalents               (649)     (53,389)

   Cash and cash equivalents - beginning                               845       58,476
                                                                 ---------    ---------

   Cash and cash equivalents - end                               $     196    $   5,087
                                                                 =========    =========

</TABLE>
<PAGE>

                          MEDI-DATA INTERNATIONAL, INC.
                          NOTES TO FINANCIAL STATEMENTS
                FOR THE SIX MONTHS ENDED AUGUST 31, 1996 AND 1995

1        SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


         BASIS OF PRESENTATION

         The  Company  is not  actively  engaged in any trade or  business.  The
         financial statements of the Company are presented on a condensed basis.
         In the opinion of  management,  the  accompanying  unaudited  financial
         information  contains all the necessary  adjustments  to fairly present
         the  financial  position of the Company as of May 31, 1996 and 1995 and
         for the periods then ended. The financial  statements should be read in
         conjunction  with the audited  financials and the related notes thereto
         included in the Company's 10-K for the year ended February 29, 1996, as
         previously filed with the Securities and Exchange Commission.

         PER SHARE DATA

         Loss per  share is based on the  weighted  average  number of shares of
         common stock outstanding during each period.

<PAGE>
                                    Part III


Item 9.  Directors, Executive Officers, Promoters and Control Person; Compliance
         with Section 16(a) of the Exchange Act.

The following table sets forth information as of September 25, 1996 with respect
to the officers and directors of the Company:

                                    Year First Appointed
Name                       Age           Director                Office Held
- ----                       ---           --------                -----------

Terry Brooks               42             1994                    President

Gary Nadelman              44             1996                    Secretary

The term of office of each of the above  directors,  pursuant  to the By-laws of
the Company,  will continue  until the next Annual Meeting of  Shareholders  and
until their respective successors are elected and qualified.

TERRY BROOKS is President  and a director of the  Company.  Ms.  Brooks has been
President of the company since  September 27, 1994 when Marc Gold resigned.  Ms.
Brooks has served as a director of the Company  since  January 24, 1994 when she
became a principal shareholder of the Company. Ms. Brooks for more than the past
six  years  has  been   principally   engaged  in  management  of  her  personal
investments.

GARY NADELMAN is Secretary and a director of the Company.  Mr. Nadelman has been
the president of Synari Inc., of New York, NY, a privately held  manufacturer of
women's sportswear and other apparel, for more than five years.


Item 10.  Executive Compensation.


No officer or director of the Company received compensation as salary during the
six months  ended  August 31,  1991 and 1995 nor during the fiscal  years  ended
February 28, 1996 and 1995.

<PAGE>

Item  11. Security Ownership of Certain Beneficial Owners and Management.


The following table sets forth the beneficial  ownership of the Company's common
stock as of  September  16,  1996  for  each  person  known  by the  Company  to
beneficially own more than five percent of the shares of the outstanding  Common
Stock,  each of the Company's  directors,  and the executive  officers listed in
Item 9.

Name of Individual                         No. of Shares       % of Outstanding
Or Identity of Group                          Owned (1)          Common Stock
- --------------------                          ---------          ------------

Terry Brooks                                5,500,000 (2)             60%

Terry Brooks IRA                            2,500,000                 27%

All Officers and Directors
as a Group (2 people)                       5,500,000 (2)             60%


(1) - Based on the  information  furnished by the beneficial  owners.  Except as
otherwise indicated herein, each beneficial owner has sole voting power and sole
investment power with respect to all shares owned.

(2) - Includes  3,000,000  shares held by Ms.  Brooks as custodian for her minor
children.


Item 12.  Certain Relationship and Related Transactions.

As noted in Item 6 the principal shareholder, Terry Brooks loaned to the Company
$100,000 in January 1994,  bearing interest at the rate of ten percent per annum
which was subsequently repaid in July of 1995. Ms. Brooks' IRA assumed a $25,000
loan from Marc Gold, the former  president of the company.  This loan was at the
same interest rate and was also repaid in July 1995.
<PAGE>


                                   SIGNATURES


Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed by the
undersigned, thereunto duly authorized.

Dated:  September 25, 1996                     MEDI DATA INTERNATIONAL, INC.


                                               /S/ TERRY BROOKS
                                                   ------------
                                                   Terry Brooks
                                                   President


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          FEB-28-1997
<PERIOD-END>                               AUG-31-1996
<CASH>                                             196
<SECURITIES>                                         0
<RECEIVABLES>                                    5,650
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 6,139
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   6,139
<CURRENT-LIABILITIES>                           60,793
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         9,213
<OTHER-SE>                                     (63,867)
<TOTAL-LIABILITY-AND-EQUITY>                     6,139
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                   250
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 (1)
<INCOME-PRETAX>                                    249
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                249
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       249
<EPS-PRIMARY>                                      .00
<EPS-DILUTED>                                      .00
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission